IO medical representative at Bristol-Myers Squibb

East Setauket, New York, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, OncologyIndustries

Requirements

本科以上医药、生命科学相关学历
熟悉当地医院的推广工作
1-3 年销售经验
有肿瘤经验者优先考虑
具备良好的人际沟通技巧
团队合作精神
能独立分析解决问题并在压力下工作

Responsibilities

有深入的产品知识和疾病领域知识
达成/超越区域目标
执行市场经理阐明的市场战略
从恰当的细分市场里甄别出目标HCP并与之合作, 达成推广计划
充分了解所在地区和所负责区域的关键HCPs
更新客户数据
协调当地的“院内会议”
及时更新HCP的信息，根据计划进行拜访
建立和维护和关键HCP的联系, 理解客户(医学)需求
达成并保持公司关于拜访率、知识水平、能力、行为和个人形象方面的要求
定期（每天）在ETMS 系统中报告拜访情况
提供准确的报告，并且根据规定的流程联系直接主管
提供给直接主管关于BMS 推广材料有效性的信息
通过参加培训、会议、和自学医学文献以发展和提高专业知识和团队成员分享自己的知识和经验
管理好专业设备和促销资料，确保完好

Skills

Pharmaceutical Sales

Oncology

HCP Engagement

Market Strategy

Sales Reporting

ETMS

Product Knowledge

Disease Expertise

Customer Data Management

Hospital Promotion

Team Collaboration

Problem Solving

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free